ClinicalTrials.gov
public full text
Public Domain
ACT-TIL and ANV419 for Advanced Melanoma.
In this study we aim to investigate safety and tolerability of tumor-infiltrating lymphocytes (TIL) adoptive cell therapy (ACT) incorporation in-vivo TIL expansion with ANV419 in patients with advanced melanoma
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer#979623
- Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia#804256
- Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias#184921
- Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells#934819
- Caractérisation in silico des répertoires génomiques des immunoglobulines et des récepteurs de cellules T chez Gorilla gorilla gorilla#374502
Record · ID 893801
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive